Vizsgálati helyszín
Hospital de Braga
Braga, 4710-243, PortugáliaMég nincs intézményhez kötve
- 6futó vizsgálat
- 13lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 19 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis15 vizsgálat
- 2. fázis3 vizsgálat
- 1/2. fázis1 vizsgálat
- Állapot
- Lezárult8 vizsgálat
- Toboroz5 vizsgálat
- Leállították5 vizsgálat
- Fut, nem toboroz1 vizsgálat
- Fő szponzor
- Biogen2 vizsgálat
- Daiichi Sankyo2 vizsgálat
- Actelion1 vizsgálat
- Celgene1 vizsgálat
- EMD Serono Research & Development Institute, Inc.1 vizsgálat
- és még 12
Futó vizsgálatok
Toboroz
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06793215· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
NCT06731478· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
NCT05897320· 3. fázis· H. Lundbeck A/S· Forrás
Toboroz
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT05519085· 3. fázis· Celgene· Forrás
Contact: Rita Gomes, Site 0056
Toboroz
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
NCT04502394· 1/2. fázis· Kartos Therapeutics, Inc.· Forrás
Contact: John Mei
Fut, nem toboroz
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
NCT03958877· 3. fázis· Biogen· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Leállították
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás
Lezárult
Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions
NCT05499832· 3. fázis· Insel Gruppe AG, University Hospital Bern· Forrás
Lezárult
Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT05287113· 2. fázis· Incyte Biosciences International Sàrl· Forrás
Lezárult
A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
NCT05455684· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Evaluation in STEMI Patients Using FDY-5301
NCT04837001· 3. fázis· Faraday Pharmaceuticals, Inc.· Forrás
Leállították
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
NCT04985968· 3. fázis· InDex Pharmaceuticals· Forrás
Leállították
Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma
NCT04854499· 2. fázis· Gilead Sciences· Forrás
Leállították
A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)
NCT04459715· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás
Leállították
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
NCT04241068· 3. fázis· Biogen· Forrás
Lezárult
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment
NCT04083235· 3. fázis· Ipsen· Forrás
Lezárult
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
NCT03734029· 3. fázis· Daiichi Sankyo· Forrás
Lezárult
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
NCT03283085· 3. fázis· Shire· Forrás
Lezárult
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
NCT03232073· 3. fázis· Actelion· Forrás
Hibát jelzek